Fianlimab flunks its big test | ApexOnco - Clinical Trials news and analysis
AI Summary
A recent clinical trial for Fianlimab ended in failure, casting doubt on its viability as a treatment option. The outcome raises concerns regarding the future of the drug within the oncology pipeline.